ENDRA Life Sciences (NDRA) Proxy Filing summary

Executive summary

• Special Meeting scheduled for October 28, 2024, to address key corporate actions.

• Shareholders are invited to vote virtually or online by October 27, 2024.

Voting matters and shareholder proposals

• Proposal to approve amendments for a reverse stock split of common stock at ratios between 1-for-4 and 1-for-35, with the final ratio to be selected by the Board within one year.

• Board recommends voting in favor of the reverse stock split proposal.

• Provision to transact other business as may properly come before the meeting or any adjournments.

Board of directors and corporate governance

• Board of Directors retains discretion to select the specific reverse split ratio and abandon the others within one year of the meeting.